Log in to save to my catalogue

Selenium and the Course of Mild Graves' Orbitopathy

Selenium and the Course of Mild Graves' Orbitopathy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_868027037

Selenium and the Course of Mild Graves' Orbitopathy

About this item

Full title

Selenium and the Course of Mild Graves' Orbitopathy

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2011-05, Vol.364 (20), p.1920-1931

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

This trial compared oral selenium, an antioxidant agent, or oral pentoxifylline, an antiinflammatory agent, with placebo in mild Graves' orbitopathy. Selenium significantly improved quality of life and eye involvement and slowed disease progression.
Approximately half the patients with Graves' disease have ocular involvement (Graves' orbitopathy...

Alternative Titles

Full title

Selenium and the Course of Mild Graves' Orbitopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_868027037

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_868027037

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1012985

How to access this item